+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Infrapopliteal Artery Stent Market - Global Forecast 2026-2032- Product Image
Infrapopliteal Artery Stent Market - Global Forecast 2026-2032- Product Image
Sale

Infrapopliteal Artery Stent Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6119434
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Infrapopliteal Artery Stent Market is projected to reach USD 2.20 Billion in 2026. It is expected to continue growing at a CAGR of 10.83%, reaching USD 4.15 Billion by 2032.

Infrapopliteal Artery Stents: Executive Summary and Strategic Context

Infrapopliteal artery stents are endovascular devices used to support blood flow in arteries below the knee, particularly in patients with peripheral artery disease and critical limb-threatening ischemia. Clinical adoption is shaped by lesion complexity, vessel diameter, calcification, runoff quality, diabetes prevalence, renal disease, and the availability of surgical and catheter-based alternatives. The field remains clinically sensitive because below-the-knee disease frequently occurs in medically complex patients and is associated with elevated risks of tissue loss, infection, and amputation.

Decision-making increasingly depends on whether a stent provides durable vessel support without creating unnecessary barriers to future intervention. Evidence quality, procedural expertise, reimbursement, device deliverability, and alignment with limb-salvage protocols are therefore central to market development.

Clinical Evidence, Device Design, and Limb-Salvage Pathways Are Reshaping Adoption

The landscape is shifting from simple vessel-opening objectives toward integrated limb-salvage strategies. Revascularization is increasingly considered alongside wound care, infection control, pressure relief, diabetes management, renal-risk mitigation, and structured follow-up. This favors technologies and treatment pathways that can address diffuse disease, severe calcification, long lesions, and vessel recoil while preserving options for repeat treatment.

Device design priorities include low-profile delivery systems, improved trackability, controlled deployment, radial strength, resistance to fracture, and compatibility with challenging below-the-knee anatomy. At the same time, clinicians continue to weigh permanent scaffolding against balloon-based and drug-delivery approaches, especially where evidence for routine primary stenting is limited or where future access may be important. Regulatory scrutiny and comparative clinical data remain influential in determining appropriate use.

Artificial Intelligence Is Strengthening Diagnosis, Planning, and Post-Procedural Surveillance

Artificial intelligence can improve the pathway surrounding infrapopliteal intervention by supporting image interpretation, vessel segmentation, lesion characterization, and procedural planning. Algorithms applied to angiography, computed tomography angiography, magnetic resonance angiography, and intravascular imaging may help identify calcification, estimate lesion length, and standardize anatomical documentation. These applications can be particularly valuable when disease is diffuse or when image quality and operator experience vary.

AI-enabled risk stratification may also support identification of patients at higher risk of restenosis, wound deterioration, readmission, or amputation. However, clinical usefulness depends on representative training data, external validation, transparent performance measures, cybersecurity, interoperability, and clinician oversight. AI should complement-not replace-vascular specialists, multidisciplinary review, and patient-specific judgment.

Regional Insights: Uneven Access and Different Evidence Environments Shape Utilization

North America combines advanced endovascular infrastructure with substantial peripheral artery disease burden, but access, reimbursement, and evidence requirements vary across systems. Europe places strong emphasis on guideline alignment, health-technology assessment, and coordinated vascular care, while national reimbursement pathways influence adoption. Asia-Pacific includes highly developed procedural markets alongside settings where diagnosis, device access, and specialist coverage remain uneven.

Latin America is characterized by variation in public and private care capacity, import dependence, and access to limb-salvage services. The Middle East is expanding specialist cardiovascular capabilities in several systems, although workforce concentration and referral patterns can affect availability. Africa faces pronounced disparities in vascular diagnostics, revascularization capacity, wound care, and follow-up, making infrastructure development and training essential to responsible adoption.

Group Insights: Trade Blocs and Alliances Create Distinct Regulatory and Access Priorities

ASEAN markets require attention to differing regulatory pathways, healthcare financing models, and specialist distribution across member states. BRICS economies span advanced device ecosystems and resource-constrained care environments, so local manufacturing, procurement, training, and evidence generation may be important alongside clinical innovation. The European Union benefits from a shared regulatory framework but retains national differences in reimbursement, procurement, and service organization.

The G7 generally combines strong clinical research capacity with demanding evidence, safety, and economic-value expectations. GCC systems often feature concentrated specialist care and investment in advanced facilities, while workforce development and referral coordination remain relevant. NATO members are not a uniform healthcare market, but alliance-linked interoperability, supply resilience, and emergency preparedness can influence interest in dependable vascular-device access.

Country Insights: Clinical Capacity, Reimbursement, and Disease Burden Differ Across Priority Markets

Australia, Canada, the United Kingdom, and the United States have established vascular services, but rural access, reimbursement structures, and multidisciplinary limb-preservation capacity differ. Germany, France, Italy, and Spain operate within Europe’s regulated environment while showing national variation in hospital procurement, clinical pathways, and health-technology assessment. These countries generally place high value on comparative evidence, procedural safety, and durable patient outcomes.

China and India combine large patient populations with rapidly evolving interventional capabilities, yet access is uneven between major urban centers and less-served areas. Japan and South Korea have sophisticated healthcare and device ecosystems, with strong interest in precision, safety, and workflow efficiency. Brazil, Mexico, and Russia face geographic and financing differences that influence specialist access, imported-device availability, and continuity of follow-up. Across all listed countries, diabetes, chronic kidney disease, smoking, aging, and delayed presentation are important clinical considerations.

Action Priorities: Build Evidence, Integrate Care, and Improve Delivery Reliability

Industry leaders should prioritize well-designed comparative studies that report limb salvage, wound healing, reintervention, patency, quality of life, and safety across relevant subgroups, including patients with diabetes, renal disease, severe calcification, and chronic limb-threatening ischemia. Evidence should reflect real-world anatomy and be paired with transparent post-market surveillance.

Commercial and clinical strategies should support multidisciplinary limb-preservation programs rather than device-only selling. Practical priorities include clinician training, case-selection tools, imaging integration, inventory resilience, and education for referring providers. Regional strategies should be adapted to reimbursement and infrastructure realities, with scalable training and service models for underserved settings. AI investments should focus on validated workflow improvements, explainability, data governance, and seamless integration into clinical systems.

Research Methodology: Evidence-Based Synthesis of Clinical, Regulatory, and Health-System Factors

This executive summary uses a structured qualitative review framework focused on infrapopliteal artery stenting and its surrounding care pathway. The assessment considers peer-reviewed clinical evidence, professional guidelines, regulatory principles, health-technology assessment practices, procedural requirements, reimbursement conditions, and documented differences in vascular-care infrastructure across the specified regions, groups, and countries.

Insights are interpreted by separating established clinical considerations from emerging technology opportunities. Particular attention is given to patient selection, lesion and vessel characteristics, procedural feasibility, comparative treatment options, outcomes reporting, access constraints, and implementation requirements. No market estimates, market shares, forecasts, or company-specific claims are included.

Conclusion: Responsible Adoption Depends on Patient Selection, Outcomes, and System Readiness

The infrapopliteal artery stent field is developing within a broader shift toward evidence-led, multidisciplinary limb preservation. Device performance remains important, but adoption also depends on anatomy, clinical indication, operator capability, follow-up, reimbursement, and the availability of complementary wound and medical care.

The strongest long-term strategies will combine rigorous comparative evidence with practical delivery support and responsible digital innovation. Leaders that align device development with validated clinical needs, regional care realities, and measurable patient outcomes will be better positioned to contribute to safer and more effective below-the-knee revascularization.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Infrapopliteal Artery Stent Market, by Product
7.1. Introduction
7.2. Bare Metal Stent
7.3. Bioresorbable Scaffold
7.4. Covered Stent
7.5. Drug Eluting Stent
7.5.1. Bioabsorbable Polymer
7.5.2. Permanent Polymer
8. Infrapopliteal Artery Stent Market, by Procedure
8.1. Introduction
8.2. Primary Implantation
8.3. Restenosis Management
8.3.1. De Novo Lesion
8.3.2. In-Stent Restenosis
9. Infrapopliteal Artery Stent Market, by Indication
9.1. Introduction
9.2. Critical Limb Ischemia
9.3. Intermittent Claudication
10. Infrapopliteal Artery Stent Market, by Implant Location
10.1. Introduction
10.2. Anterior Tibial Artery
10.3. Peroneal Artery
10.4. Posterior Tibial Artery
11. Infrapopliteal Artery Stent Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Center
11.3. Hospital
11.4. Specialty Clinic
12. Infrapopliteal Artery Stent Market, by Distribution Channel
12.1. Introduction
12.2. Direct Tender
12.3. Distributor
12.4. Online Channel
13. Infrapopliteal Artery Stent Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Infrapopliteal Artery Stent Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Infrapopliteal Artery Stent Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. B. Braun Melsungen AG
17.3. Becton, Dickinson and Company
17.4. Biotronik SE & Co. KG
17.5. Boston Scientific Corporation
17.6. C.R. Bard, Inc.
17.7. Cardiovascular Systems, Inc.
17.8. Cook Medical, Inc.
17.9. Cordis LLC
17.10. Endologix, Inc.
17.11. Gore Medical
17.12. iVascular S.L.U.
17.13. Jotec GmbH
17.14. Lombard Medical Technologies
17.15. Medtronic plc
17.16. Meril Life Sciences Pvt. Ltd.
17.17. MicroPort Scientific Corporation
17.18. Synectic Medical Limited
17.19. Teleflex Incorporated
17.20. Terumo Corporation
17.21. Translumina GmbH
17.22. W. L. Gore & Associates, Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Infrapopliteal Artery Stent Market, Years Considered for the Study
FIGURE 2. Global Infrapopliteal Artery Stent Market, Research Design
FIGURE 3. Global Infrapopliteal Artery Stent Market, Research Framework
FIGURE 4. Global Infrapopliteal Artery Stent Market, Data Triangulation
FIGURE 5. Global Infrapopliteal Artery Stent Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Infrapopliteal Artery Stent Market Size, by Product, 2025 vs 2032 (%)
FIGURE 7. Global Infrapopliteal Artery Stent Market Size, by Product, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Infrapopliteal Artery Stent Market Size, by Procedure, 2025 vs 2032 (%)
FIGURE 9. Global Infrapopliteal Artery Stent Market Size, by Procedure, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Infrapopliteal Artery Stent Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 11. Global Infrapopliteal Artery Stent Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Infrapopliteal Artery Stent Market Size, by Implant Location, 2025 vs 2032 (%)
FIGURE 13. Global Infrapopliteal Artery Stent Market Size, by Implant Location, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Infrapopliteal Artery Stent Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Infrapopliteal Artery Stent Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 17. Global Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Infrapopliteal Artery Stent Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Infrapopliteal Artery Stent Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Infrapopliteal Artery Stent Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Infrapopliteal Artery Stent Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Infrapopliteal Artery Stent Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Infrapopliteal Artery Stent Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Infrapopliteal Artery Stent Market Segmentation & Coverage
TABLE 2. Global Infrapopliteal Artery Stent Market Size, 2017-2032 (USD Million)
TABLE 3. Global Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 4. Global Bare Metal Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Bare Metal Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Bare Metal Stent Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Bioresorbable Scaffold Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Bioresorbable Scaffold Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Bioresorbable Scaffold Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Covered Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Covered Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Covered Stent Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Drug Eluting Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Drug Eluting Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Drug Eluting Stent Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Bioabsorbable Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Bioabsorbable Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Bioabsorbable Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Permanent Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Permanent Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Permanent Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 23. Global Primary Implantation Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Primary Implantation Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Primary Implantation Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Restenosis Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Restenosis Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Restenosis Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global De Novo Lesion Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global De Novo Lesion Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global De Novo Lesion Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global In-Stent Restenosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global In-Stent Restenosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global In-Stent Restenosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 36. Global Critical Limb Ischemia Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Critical Limb Ischemia Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Critical Limb Ischemia Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Intermittent Claudication Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Intermittent Claudication Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Intermittent Claudication Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 43. Global Anterior Tibial Artery Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Anterior Tibial Artery Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Anterior Tibial Artery Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Peroneal Artery Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Peroneal Artery Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Peroneal Artery Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Posterior Tibial Artery Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Posterior Tibial Artery Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Posterior Tibial Artery Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 53. Global Ambulatory Surgical Center Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Ambulatory Surgical Center Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Ambulatory Surgical Center Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Specialty Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Specialty Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Specialty Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 63. Global Direct Tender Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Direct Tender Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Direct Tender Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Distributor Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Distributor Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Distributor Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Online Channel Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Online Channel Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Online Channel Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Infrapopliteal Artery Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Infrapopliteal Artery Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 82. North America Infrapopliteal Artery Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. North America Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 84. North America Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 85. North America Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 86. North America Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 87. North America Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 88. North America Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 89. North America Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. North America Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 91. Latin America Infrapopliteal Artery Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Latin America Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 93. Latin America Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 94. Latin America Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 95. Latin America Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 96. Latin America Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 97. Latin America Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 98. Latin America Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. Latin America Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 100. Europe Infrapopliteal Artery Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Europe Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 102. Europe Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 103. Europe Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 104. Europe Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 105. Europe Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 106. Europe Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 107. Europe Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. Europe Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 109. Middle East Infrapopliteal Artery Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Middle East Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 111. Middle East Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 112. Middle East Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 113. Middle East Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 114. Middle East Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 115. Middle East Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 116. Middle East Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. Middle East Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 118. Africa Infrapopliteal Artery Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Africa Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 120. Africa Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 121. Africa Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 122. Africa Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 123. Africa Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 124. Africa Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 125. Africa Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. Africa Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 127. Global Infrapopliteal Artery Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. ASEAN Infrapopliteal Artery Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. ASEAN Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 130. ASEAN Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 131. ASEAN Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 132. ASEAN Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 133. ASEAN Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 134. ASEAN Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 135. ASEAN Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. ASEAN Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 137. GCC Infrapopliteal Artery Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. GCC Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 139. GCC Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 140. GCC Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 141. GCC Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 142. GCC Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 143. GCC Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 144. GCC Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. GCC Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 146. European Union Infrapopliteal Artery Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. European Union Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 148. European Union Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 149. European Union Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 150. European Union Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 151. European Union Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 152. European Union Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 153. European Union Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. European Union Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 155. BRICS Infrapopliteal Artery Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. BRICS Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 157. BRICS Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 158. BRICS Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 159. BRICS Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 160. BRICS Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 161. BRICS Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 162. BRICS Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. BRICS Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 164. G7 Infrapopliteal Artery Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 165. G7 Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 166. G7 Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 167. G7 Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 168. G7 Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 169. G7 Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 170. G7 Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 171. G7 Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. G7 Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 173. NATO Infrapopliteal Artery Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. NATO Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 175. NATO Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 176. NATO Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 177. NATO Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 178. NATO Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 179. NATO Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 180. NATO Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. NATO Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 182. Global Infrapopliteal Artery Stent Market Size, by Country, 2017-2032 (USD Million)
TABLE 183. United States Infrapopliteal Artery Stent Market Size, 2017-2032 (USD Million)
TABLE 184. United States Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 185. United States Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 186. United States Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 187. United States Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 188. United States Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 189. United States Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 190. United States Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 191. United States Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 192. Canada Infrapopliteal Artery Stent Market Size, 2017-2032 (USD Million)
TABLE 193. Canada Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 194. Canada Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 195. Canada Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 196. Canada Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 197. Canada Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 198. Canada Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 199. Canada Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. Canada Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 201. Mexico Infrapopliteal Artery Stent Market Size, 2017-2032 (USD Million)
TABLE 202. Mexico Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 203. Mexico Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 204. Mexico Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 205. Mexico Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 206. Mexico Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 207. Mexico Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 208. Mexico Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. Mexico Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 210. Brazil Infrapopliteal Artery Stent Market Size, 2017-2032 (USD Million)
TABLE 211. Brazil Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 212. Brazil Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 213. Brazil Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 214. Brazil Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 215. Brazil Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 216. Brazil Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 217. Brazil Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. Brazil Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 219. United Kingdom Infrapopliteal Artery Stent Market Size, 2017-2032 (USD Million)
TABLE 220. United Kingdom Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 221. United Kingdom Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 222. United Kingdom Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 223. United Kingdom Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 224. United Kingdom Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 225. United Kingdom Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 226. United Kingdom Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. United Kingdom Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 228. Germany Infrapopliteal Artery Stent Market Size, 2017-2032 (USD Million)
TABLE 229. Germany Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 230. Germany Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 231. Germany Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 232. Germany Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 233. Germany Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 234. Germany Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 235. Germany Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. Germany Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 237. France Infrapopliteal Artery Stent Market Size, 2017-2032 (USD Million)
TABLE 238. France Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 239. France Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 240. France Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 241. France Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 242. France Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 243. France Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 244. France Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. France Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 246. Russia Infrapopliteal Artery Stent Market Size, 2017-2032 (USD Million)
TABLE 247. Russia Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 248. Russia Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 249. Russia Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 250. Russia Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 251. Russia Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 252. Russia Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 253. Russia Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. Russia Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 255. Italy Infrapopliteal Artery Stent Market Size, 2017-2032 (USD Million)
TABLE 256. Italy Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 257. Italy Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 258. Italy Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 259. Italy Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 260. Italy Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 261. Italy Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 262. Italy Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. Italy Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 264. Spain Infrapopliteal Artery Stent Market Size, 2017-2032 (USD Million)
TABLE 265. Spain Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 266. Spain Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 267. Spain Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 268. Spain Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 269. Spain Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 270. Spain Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 271. Spain Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 272. Spain Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 273. China Infrapopliteal Artery Stent Market Size, 2017-2032 (USD Million)
TABLE 274. China Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 275. China Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 276. China Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 277. China Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 278. China Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 279. China Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 280. China Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 281. China Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 282. India Infrapopliteal Artery Stent Market Size, 2017-2032 (USD Million)
TABLE 283. India Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 284. India Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 285. India Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 286. India Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 287. India Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 288. India Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 289. India Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 290. India Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 291. Japan Infrapopliteal Artery Stent Market Size, 2017-2032 (USD Million)
TABLE 292. Japan Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 293. Japan Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 294. Japan Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 295. Japan Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 296. Japan Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 297. Japan Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 298. Japan Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. Japan Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 300. Australia Infrapopliteal Artery Stent Market Size, 2017-2032 (USD Million)
TABLE 301. Australia Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 302. Australia Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 303. Australia Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 304. Australia Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 305. Australia Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 306. Australia Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 307. Australia Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 308. Australia Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 309. South Korea Infrapopliteal Artery Stent Market Size, 2017-2032 (USD Million)
TABLE 310. South Korea Infrapopliteal Artery Stent Market Size, by Product, 2017-2032 (USD Million)
TABLE 311. South Korea Infrapopliteal Artery Stent Market Size, by Drug Eluting Stent, 2017-2032 (USD Million)
TABLE 312. South Korea Infrapopliteal Artery Stent Market Size, by Procedure, 2017-2032 (USD Million)
TABLE 313. South Korea Infrapopliteal Artery Stent Market Size, by Restenosis Management, 2017-2032 (USD Million)
TABLE 314. South Korea Infrapopliteal Artery Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 315. South Korea Infrapopliteal Artery Stent Market Size, by Implant Location, 2017-2032 (USD Million)
TABLE 316. South Korea Infrapopliteal Artery Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 317. South Korea Infrapopliteal Artery Stent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 318. Global Infrapopliteal Artery Stent Market Share, by Key Player, 2025
TABLE 319. Global Infrapopliteal Artery Stent Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • C.R. Bard, Inc.
  • Cardiovascular Systems, Inc.
  • Cook Medical, Inc.
  • Cordis LLC
  • Endologix, Inc.
  • Gore Medical
  • iVascular S.L.U.
  • Jotec GmbH
  • Lombard Medical Technologies
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Synectic Medical Limited
  • Teleflex Incorporated
  • Terumo Corporation
  • Translumina GmbH
  • W. L. Gore & Associates, Inc.

Related Topics

Related Reports

Peripheral Stent - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Peripheral Stent - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 115 Pages
  • Global
From
Peripheral Stent Graft Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type - Product Image

Peripheral Stent Graft Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 91 Pages
  • Global
From
Peripheral Stent Market Outlook 2026-2034: Market Share, and Growth Analysis by Product (Bare-Metal Stents (BMS), Covered Stents, Drug-Eluting Stents (DES), Bio-resorbable Vascular Scaffolds (BVS)), Artery Type, Material, Deployment Mechanism - Product Image

Peripheral Stent Market Outlook 2026-2034: Market Share, and Growth Analysis by Product (Bare-Metal Stents (BMS), Covered Stents, Drug-Eluting Stents (DES), Bio-resorbable Vascular Scaffolds (BVS)), Artery Type, Material, Deployment Mechanism

  • Report
  • 160 Pages
  • Global
From
Absorbable Coronary Artery Sirolimus-Eluting Stent System Market - Global Forecast 2026-2032 - Product Image

Absorbable Coronary Artery Sirolimus-Eluting Stent System Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Vascular Stent Market - Global Forecast 2026-2032 - Product Image

Vascular Stent Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.